AzTrials
AzTrials

Sedation ProblemsNCT05793658

Role of Respiratory Rate Derived From Capnography in Sedated Patients

A study testing Standard capnography and Modified capnography in people with Sedation Problems, run by Al Jedaani Hospital at 1 site in Saudi Arabia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Although appropriate sedation is recommended during colonoscopy, patients are at risk for adverse events e.g hypoventilation and hypoxemia due to inadvertent oversedation. The aim of this study was to evaluate the benefit of additional quantitative capnography monitoring ( respiratory rate )in management of patient… Read more about this study

Who is it for?
Ages 20 to 50 years
Conditions the study is for
Sedation Problems
What is being tested?
Standard capnography and Modified capnography
Could I receive a placebo?
No, everyone receives an active treatment
How many people
74 participants
Where
1 siteSaudi Arabia
Study dates
25 Nov 2022to 20 Feb 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 50 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • ASA 1 and 2 adult patients
  • Age from 20 to 50 years old
  • elective colonoscopy

Who cannot join

  • American Society of Anesthesiologists (ASA) above Class II
  • History of psychiatric or neurological disease

Trial locations and contacts

1 site in 1 country.

Saudi Arabia1 site
  • Al Jedaani group of hospitals

    Jeddah, Meccah, 21462/7500

Other trials in Saudi Arabia

About this study

Official title: Is Respiratory Rate Derived From Capnography Can Prevent Adverse Events Occurred in Sedated Patients.

Although appropriate sedation is recommended during colonoscopy, patients are at risk for adverse events e.g hypoventilation and hypoxemia due to inadvertent oversedation. The aim of this study was to evaluate the benefit of additional quantitative capnography monitoring ( respiratory rate )in management of patient undergoing colonoscopy under sedation in preventing or reducing the incidence of adverse events and also determine when to start the procedure and when to give and not to give increments of sedative drugs during the procedure.

Being tested
Standard capnography, Modified capnography
Keywords
Sedation, capnography, Respiratory rate, colonoscopy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Standard capnographyProcedure or surgery

    Also called Qualitative capnograpyhy

    Patients undergoing colonoscopy under sedation were randomly assigned to receive standard capnography monitoring or modified capnography monitoring which can be achieved by tucking capnography probe under the face mask.74 patients were enrolled. Patient characteristics were well balanced between the two groups 37 patients in each group.

  • Modified capnographyProcedure or surgery

    Also called Quantitative capnography

    If Respiratory rate below 14 b/m: more sedation isn't not advised and the patient may develop airway obstruction and needs airway intervention ( like jaw thrust or oral airway) If respiratory rate more than 20 b/m it means this patient is prone to awake or to move and this patient in need for incremental dose of sedative drug ( e.g 20 to 30 mg propofol) Also roughly speaking respiratory rate from 16 to 18 b/m is the target

Study groups in NCT05793658
Study groupRoleWhat they receive
Sedation with standard capnographyActive comparator37 patient Sedation using midazolam + propofol for colonoscopy
Receives: Procedure: Standard capnography
Sedation with modified capnographyActive comparator37 patients in Sedation using midazolam + fentanyl + propofol for colonoscopy
Receives: Procedure: Modified capnography

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Hypoxemia

    Detected by pulse oximeter

    Measured: 1 hours

Secondary outcomes (4)
  1. Patient movements during the procedure

    Measured by questionnaire to the gastroenterologist (scale from 1 to 5)

    Measured: 1 hour

  2. Effort exerted by the anesthesiologist ( the provider)

    Measured by questionnaire ( scale from 1 to 5 )

    Measured: 1 hour

  3. Patient satisfaction

    Measured by questionnaire ( scale from 1 to 5 )

    Measured: 1 hour

  4. Gastroenterologist satisfaction

    Measured by questionnaire ( scale from 1 to 5 )

    Measured: 1 hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Mar 2023
  2. Study start25 Nov 2022
  3. Primary completion20 Feb 2023
  4. Study completion20 Feb 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
74 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05793658
Sponsor's protocol ID
1/5/22
Status last verified
Mar 2023
First submitted
28 Feb 2023
Last updated
31 Mar 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Standard capnography and Modified capnography in people with Sedation Problems, run by Al Jedaani Hospital at 1 site in Saudi Arabia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Hypoxemia (time frame: 1 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in